Cargando…

Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation

IMPORTANCE: Myocardial injury is a common feature of patients with SARS-CoV-2 infection. However, the cardiac inflammatory processes associated with SARS-CoV-2 infection are not completely understood. OBJECTIVE: To investigate the inflammatory cardiac phenotype associated with SARS-CoV-2 infection c...

Descripción completa

Detalles Bibliográficos
Autores principales: Weckbach, Ludwig T., Schweizer, Lisa, Kraechan, Angelina, Bieber, Stephanie, Ishikawa-Ankerhold, Hellen, Hausleiter, Jörg, Massberg, Steffen, Straub, Tobias, Klingel, Karin, Grabmaier, Ulrich, Zwiebel, Maximilian, Mann, Matthias, Schulz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674808/
https://www.ncbi.nlm.nih.gov/pubmed/34910083
http://dx.doi.org/10.1001/jamacardio.2021.5133
_version_ 1784615753254699008
author Weckbach, Ludwig T.
Schweizer, Lisa
Kraechan, Angelina
Bieber, Stephanie
Ishikawa-Ankerhold, Hellen
Hausleiter, Jörg
Massberg, Steffen
Straub, Tobias
Klingel, Karin
Grabmaier, Ulrich
Zwiebel, Maximilian
Mann, Matthias
Schulz, Christian
author_facet Weckbach, Ludwig T.
Schweizer, Lisa
Kraechan, Angelina
Bieber, Stephanie
Ishikawa-Ankerhold, Hellen
Hausleiter, Jörg
Massberg, Steffen
Straub, Tobias
Klingel, Karin
Grabmaier, Ulrich
Zwiebel, Maximilian
Mann, Matthias
Schulz, Christian
author_sort Weckbach, Ludwig T.
collection PubMed
description IMPORTANCE: Myocardial injury is a common feature of patients with SARS-CoV-2 infection. However, the cardiac inflammatory processes associated with SARS-CoV-2 infection are not completely understood. OBJECTIVE: To investigate the inflammatory cardiac phenotype associated with SARS-CoV-2 infection compared with viral myocarditis, immune-mediated myocarditis, and noninflammatory cardiomyopathy by integrating histologic, transcriptomic, and proteomic profiling. DESIGN, SETTING, AND PARTICIPANTS: This case series was a cooperative study between the Ludwig Maximilian University Hospital Munich and the Cardiopathology Referral Center at the University of Tübingen in Germany. A cohort of 19 patients with suspected myocarditis was examined; of those, 5 patients were hospitalized with SARS-CoV-2 infection between March and May 2020. Cardiac tissue specimens from those 5 patients were compared with specimens from 5 patients with immune-mediated myocarditis, 4 patients with non–SARS-CoV-2 viral myocarditis, and 5 patients with noninflammatory cardiomyopathy, collected from January to August 2019. EXPOSURES: Endomyocardial biopsy. MAIN OUTCOMES AND MEASURES: The inflammatory cardiac phenotypes were measured by immunohistologic analysis, RNA exome capture sequencing, and mass spectrometry–based proteomic analysis of endomyocardial biopsy specimens. RESULTS: Among 19 participants, the median age was 58 years (range, 37-76 years), and 15 individuals (79%) were male. Data on race and ethnicity were not collected. The abundance of CD163+ macrophages was generally higher in the cardiac tissue of patients with myocarditis, whereas lymphocyte counts were lower in the tissue of patients with SARS-CoV-2 infection vs patients with non–SARS-CoV-2 virus-associated and immune-mediated myocarditis. Among those with SARS-CoV-2 infection, components of the complement cascade, including C1q subunits (transcriptomic analysis: 2.5-fold to 3.6-fold increase; proteomic analysis: 2.0-fold to 3.4-fold increase) and serine/cysteine proteinase inhibitor clade G member 1 (transcriptomic analysis: 1.7-fold increase; proteomic analysis: 2.6-fold increase), belonged to the most commonly upregulated transcripts and differentially abundant proteins. In cardiac macrophages, the abundance of C1q was highest in SARS-CoV-2 infection. Assessment of important signaling cascades identified an upregulation of the serine/threonine mitogen-activated protein kinase pathways. CONCLUSIONS AND RELEVANCE: This case series found that the cardiac immune signature varied in inflammatory conditions with different etiologic characteristics. Future studies are needed to examine the role of these immune pathways in myocardial inflammation.
format Online
Article
Text
id pubmed-8674808
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-86748082022-01-04 Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation Weckbach, Ludwig T. Schweizer, Lisa Kraechan, Angelina Bieber, Stephanie Ishikawa-Ankerhold, Hellen Hausleiter, Jörg Massberg, Steffen Straub, Tobias Klingel, Karin Grabmaier, Ulrich Zwiebel, Maximilian Mann, Matthias Schulz, Christian JAMA Cardiol Original Investigation IMPORTANCE: Myocardial injury is a common feature of patients with SARS-CoV-2 infection. However, the cardiac inflammatory processes associated with SARS-CoV-2 infection are not completely understood. OBJECTIVE: To investigate the inflammatory cardiac phenotype associated with SARS-CoV-2 infection compared with viral myocarditis, immune-mediated myocarditis, and noninflammatory cardiomyopathy by integrating histologic, transcriptomic, and proteomic profiling. DESIGN, SETTING, AND PARTICIPANTS: This case series was a cooperative study between the Ludwig Maximilian University Hospital Munich and the Cardiopathology Referral Center at the University of Tübingen in Germany. A cohort of 19 patients with suspected myocarditis was examined; of those, 5 patients were hospitalized with SARS-CoV-2 infection between March and May 2020. Cardiac tissue specimens from those 5 patients were compared with specimens from 5 patients with immune-mediated myocarditis, 4 patients with non–SARS-CoV-2 viral myocarditis, and 5 patients with noninflammatory cardiomyopathy, collected from January to August 2019. EXPOSURES: Endomyocardial biopsy. MAIN OUTCOMES AND MEASURES: The inflammatory cardiac phenotypes were measured by immunohistologic analysis, RNA exome capture sequencing, and mass spectrometry–based proteomic analysis of endomyocardial biopsy specimens. RESULTS: Among 19 participants, the median age was 58 years (range, 37-76 years), and 15 individuals (79%) were male. Data on race and ethnicity were not collected. The abundance of CD163+ macrophages was generally higher in the cardiac tissue of patients with myocarditis, whereas lymphocyte counts were lower in the tissue of patients with SARS-CoV-2 infection vs patients with non–SARS-CoV-2 virus-associated and immune-mediated myocarditis. Among those with SARS-CoV-2 infection, components of the complement cascade, including C1q subunits (transcriptomic analysis: 2.5-fold to 3.6-fold increase; proteomic analysis: 2.0-fold to 3.4-fold increase) and serine/cysteine proteinase inhibitor clade G member 1 (transcriptomic analysis: 1.7-fold increase; proteomic analysis: 2.6-fold increase), belonged to the most commonly upregulated transcripts and differentially abundant proteins. In cardiac macrophages, the abundance of C1q was highest in SARS-CoV-2 infection. Assessment of important signaling cascades identified an upregulation of the serine/threonine mitogen-activated protein kinase pathways. CONCLUSIONS AND RELEVANCE: This case series found that the cardiac immune signature varied in inflammatory conditions with different etiologic characteristics. Future studies are needed to examine the role of these immune pathways in myocardial inflammation. American Medical Association 2021-12-15 2022-03 /pmc/articles/PMC8674808/ /pubmed/34910083 http://dx.doi.org/10.1001/jamacardio.2021.5133 Text en Copyright 2021 Weckbach LT et al. JAMA Cardiology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Weckbach, Ludwig T.
Schweizer, Lisa
Kraechan, Angelina
Bieber, Stephanie
Ishikawa-Ankerhold, Hellen
Hausleiter, Jörg
Massberg, Steffen
Straub, Tobias
Klingel, Karin
Grabmaier, Ulrich
Zwiebel, Maximilian
Mann, Matthias
Schulz, Christian
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation
title Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation
title_full Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation
title_fullStr Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation
title_full_unstemmed Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation
title_short Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation
title_sort association of complement and mapk activation with sars-cov-2–associated myocardial inflammation
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674808/
https://www.ncbi.nlm.nih.gov/pubmed/34910083
http://dx.doi.org/10.1001/jamacardio.2021.5133
work_keys_str_mv AT weckbachludwigt associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT schweizerlisa associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT kraechanangelina associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT bieberstephanie associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT ishikawaankerholdhellen associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT hausleiterjorg associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT massbergsteffen associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT straubtobias associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT klingelkarin associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT grabmaierulrich associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT zwiebelmaximilian associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT mannmatthias associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation
AT schulzchristian associationofcomplementandmapkactivationwithsarscov2associatedmyocardialinflammation